A blood test that can detect alzheimer's disease is now available, but it is unclear whether it should be taken at home. The test can reportedly predict the start of symptoms and detect early signs of the disease, but its use is not yet widely covered by healthcare providers, including medicare. Researchers and doctors are weighing the benefits and implications of the test, which may mark a significant development in alzheimer's research.